VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NVAXNovavax, Inc.
$8.88$1.5B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksNVAXQuarterly Financials

Novavax, Inc. (NVAX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Novavax, Inc. (NVAX) quarterly income statement — complete revenue, gross profit & net income history

NVAX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue139.51M147.14M70.44M239.24M666.65M88.31M84.51M415.48M93.86M291.34M22.06M424.43M
Revenue Growth %-79.07%66.61%-16.64%-42.42%610.3%-69.69%283.03%-2.11%1560.1%1.22%-97%128.28%
Cost of Goods Sold30.7M25.2M21.5M14.22M14.12M36.67M60.62M46.24M48.81M148.88M98.93M55.78M
COGS % of Revenue22%17.13%30.51%5.95%2.12%41.52%71.73%11.13%52%51.1%448.37%13.14%
Gross Profit108.82M121.94M48.95M225.01M652.54M51.64M23.89M369.24M45.05M142.47M-76.86M368.65M
Gross Margin %78%82.87%69.49%94.05%97.88%58.48%28.27%88.87%48%48.9%-348.37%86.86%
Gross Profit Growth %-83.32%136.12%104.87%-39.06%1348.61%-63.75%131.08%0.16%211.19%34.32%-125.62%532.93%
Operating Expenses124.25M100.92M226.97M119.34M137.03M182.72M157.91M208.24M183.78M326.03M48.77M313.19M
OpEx % of Revenue89.06%68.58%322.19%49.89%20.55%206.91%186.85%50.12%195.81%111.91%221.03%73.79%
Selling, General & Admin28.78M26.94M31.66M40.61M48.09M78.34M70.75M101.3M82.3M155.24M107.46M93.72M
SG&A % of Revenue20.63%18.31%44.94%16.98%7.21%88.71%83.71%24.38%87.69%53.28%487.04%22.08%
Research & Development95.47M73.98M98.27M77.63M88.94M104.38M87.16M106.95M92.68M164.7M106.23M219.47M
R&D % of Revenue68.43%50.28%139.5%32.45%13.34%118.2%103.14%25.74%98.75%56.53%481.46%51.71%
Other Operating Expenses001000K1000K00001000K1000K-1000K0
Operating Income-15.43M21.02M-178.02M105.67M515.51M-131.08M-134.02M161M-138.73M-183.57M-125.63M55.46M
Operating Margin %-11.06%14.29%-252.7%44.17%77.33%-148.43%-158.58%38.75%-147.81%-63.01%-569.4%13.07%
Operating Income Growth %-102.99%116.04%-32.83%-34.37%471.59%28.59%-6.68%190.31%55.64%24.73%1.22%111.48%
EBITDA-15.43M26.14M-171.43M113.23M523.85M-118.56M-121.32M172.13M-126.58M-172.77M-114.31M65.52M
EBITDA Margin %-11.06%17.77%-243.36%47.33%78.58%-134.26%-143.55%41.43%-134.87%-59.3%-518.09%15.44%
EBITDA Growth %-102.95%122.05%-41.31%-34.22%513.84%31.38%-6.13%162.7%58.32%26.81%3.81%113.76%
D&A (Non-Cash Add-back)05.13M6.58M7.56M8.34M12.52M12.7M11.13M12.15M10.79M11.32M10.07M
EBIT-15.43M23.73M-197.55M112.97M525.57M-66M-118.1M168.73M-141.18M-172.58M-128.61M60.99M
Net Interest Income4.9M-5.82M-5.48M-5.52M-5.72M-7.58M-4.24M-4.14M-4.11M-4.12M-2.86M-3.12M
Interest Income000000000000
Interest Expense-4.9M5.82M5.48M5.52M5.72M7.58M4.24M4.14M4.11M4.12M2.86M3.12M
Other Income/Expense6.92M-3.12M-25.02M1.78M4.33M57.5M11.69M3.59M-6.56M6.87M-5.84M2.41M
Pretax Income-8.51M17.9M-203.04M107.45M519.85M-73.58M-122.33M164.59M-145.29M-176.7M-131.47M57.87M
Pretax Margin %-6.1%12.17%-288.22%44.91%77.98%-83.32%-144.75%39.61%-154.8%-60.65%-595.87%13.63%
Income Tax985K376K-657K946K1.2M7.45M-1.03M2.21M2.26M1.69M-697K-143K
Effective Tax Rate %-11.58%2.1%0.32%0.88%0.23%-10.12%0.84%1.34%-1.56%-0.96%0.53%-0.25%
Net Income-9.49M17.53M-202.38M106.51M518.65M-81.03M-121.3M162.38M-147.55M-178.39M-130.78M58.01M
Net Margin %-6.8%11.91%-287.29%44.52%77.8%-91.76%-143.53%39.08%-157.21%-61.23%-592.71%13.67%
Net Income Growth %-101.83%121.63%-66.84%-34.41%451.51%54.58%7.25%179.93%49.8%2.12%22.44%111.36%
Net Income (Continuing)-9.49M17.53M-202.38M106.51M518.65M-81.03M-121.3M162.38M-147.55M-178.39M-130.78M58.01M
Discontinued Operations000000000000
Minority Interest000000000000
EPS (Diluted)-0.060.11-1.250.602.93-0.51-0.760.99-1.05-1.44-1.260.58
EPS Growth %-102.05%121.57%-64.47%-39.39%379.05%64.58%39.68%70.69%69.21%36.84%41.4%108.88%
EPS (Basic)-0.060.11-1.250.663.22-0.51-0.761.11-1.05-1.44-1.260.65
Diluted Shares Outstanding163.28M173.1M162.35M177.22M177.63M160.24M160.05M165.85M139.92M123.68M103.43M104.06M
Basic Shares Outstanding163.28M161.99M162.35M162.02M161.05M160.24M160.05M148.38M139.92M123.68M103.43M89.36M
Dividend Payout Ratio------------